Utama › Psoriasis › California
Kajian klinikal Psoriasis di California
13 kajian untuk Psoriasis sedang mencari peserta di lokasi di California.
Bandar di California
Teks kajian rasmi (Bahasa Inggeris)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- LEO Pharma Investigational Site, Fountain Valley
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07013201A Study to Assess Deucravacitinib Safety in Pregnancy
- University of California San Diego, La Jolla
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Semua umur · Wanita · Dikemas kini 1 Okt 2026 · NCT07017699Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
- Vanda Investigational Site, Fremont
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07362017The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
- UCSF Mt Zion Campus, San Francisco
- San Francisco VA Medical Center, San Francisco
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07487831A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- First OC Dermatology Research Inc, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Metropolis Dermatology, Los Angeles
- dan 1 lagi
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Local Institution - 0025, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Dermatology Research Associates, Los Angeles
- dan 3 lagi
Mengambil pesertaFasa 3
Umur 12 hingga 17 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06979453A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- Ppp001 50176, Fremont
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07219420The Effects of Audio-Based Therapy on Anxiety in Psoriasis
- Liao Lab at UCSF, San Francisco
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2026 · NCT07390487A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, Chula Vista
- Study Center, Fountain Valley
- Study Center, Fremont
- dan 3 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 9 Jul 2026 · NCT07489885Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
- University of California, Davis - Dermatology Department, Sacramento
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jun 2026 · NCT06574178Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
- Kinetic Clinical Research, Anaheim
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 7 Ogo 2025 · NCT06846710Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
Mengambil pesertaKajian pemerhatian
Semua umur · Wanita · Dikemas kini 28 Jan 2025 · NCT02103361Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.